We are live on
!
Find out more
CA
Cornerstone Advisors Portfolio holdings
AUM
$3.04B
Turnover
28.46%
1-Year Est. Return
36.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+36.62%
3 Year Est. Return
+108.19%
5 Year Est. Return
+137.76%
10 Year Est. Return
–
AUM
$545M
AUM Growth
-$8.77M
(-1.6%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
23.67%
Holding
270
New
49
Increased
48
Reduced
49
Closed
37
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$10.3M |
| 2 |
UnitedHealth
UNH
|
+$5.44M |
| 3 |
Boeing
BA
|
+$3.72M |
| 4 |
Comcast
CMCSA
|
+$3M |
| 5 |
Honeywell
HON
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.63M |
| 2 |
Morgan Stanley China A Share Fund
CAF
|
+$6.28M |
| 3 |
Merck
MRK
|
+$5.74M |
| 4 |
Philip Morris
PM
|
+$4.97M |
| 5 |
Chevron
CVX
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.38% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 9.75% |
| 5 | Technology | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$286B
| $2.9M | 0.53% |
65,000
+14,000
| +27% | +$604K |
2017 Q1
1 quarter
|
|
52
Abbott
ABT
$181B
| $2.82M | 0.52% |
58,000
| – | – |
2016 Q4
2 quarters
|
|
53
Thermo Fisher Scientific
TMO
$258B
| $2.79M | 0.51% |
16,000
| – | – |
2013 Q3
15 quarters
|
|
54
Alphabet (Google) Class A
GOOGL
$4.27T
| $2.79M | 0.51% |
60,000
| – | – |
2015 Q4
6 quarters
|
|
55
CVS Health
CVS
$118B
| $2.74M | 0.5% |
34,000
+29,000
| +580% | +$2.29M |
2017 Q1
1 quarter
|
|
|
MGU
56
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
| $2.69M | 0.49% |
107,905
-35,364
| -25% | -$850K |
2015 Q2
8 quarters
|
|
|
RAI
57
DELISTED
Reynolds American Inc
RAI
| $2.67M | 0.49% |
41,000
| – | – |
2015 Q3
7 quarters
|
|
58
DuPont de Nemours
DD
$17.8B
| $2.55M | 0.47% |
15,993
| – | – |
2013 Q2
16 quarters
|
|
59
Gilead Sciences
GILD
$195B
| $2.55M | 0.47% |
36,000
+16,000
| +80% | +$1.06M |
2017 Q1
1 quarter
|
|
|
60
Honeywell
HON
$66.7B
| $2.53M | 0.46% |
+21,033
| New | +$2.48M |
2017 Q2
0 quarters
|
|
61
Starbucks
SBUX
$110B
| $2.51M | 0.46% |
43,000
| – | – |
2015 Q3
7 quarters
|
|
62
Source Capital
SOR
$372M
| $2.44M | 0.45% |
63,069
+12,993
| +26% | +$496K |
2016 Q4
2 quarters
|
|
63
iShares Core S&P 500 ETF
IVV
$889B
| $2.43M | 0.45% |
10,000
-10,000
| -50% | -$2.41M |
2013 Q3
15 quarters
|
|
64
GDL Fund
GDL
$89.3M
| $2.43M | 0.45% |
236,927
-87,579
| -27% | -$880K |
2014 Q2
12 quarters
|
|
|
65
Morgan Stanley China A Share Fund
CAF
$228M
| $2.42M | 0.44% |
108,230
-303,612
| -74% | -$6.28M |
2016 Q1
5 quarters
|
|
|
INF
66
DELISTED
BROOKFIELD GLOBAL LISTED INFRASTRUCTURE INCOME FUND INC.
INF
| $2.32M | 0.43% |
168,586
+39,159
| +30% | +$534K |
2017 Q1
1 quarter
|
|
67
JPMorgan Chase
JPM
$891B
| $2.29M | 0.42% |
+25,000
| New | +$2.16M |
2017 Q2
0 quarters
|
|
68
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.36B
| $2.25M | 0.41% |
171,857
-314,766
| -65% | -$4.14M |
2014 Q4
10 quarters
|
|
69
Chubb
CB
$136B
| $2.21M | 0.41% |
15,203
| – | – |
2015 Q1
9 quarters
|
|
70
Danaher
DHR
$163B
| $2.19M | 0.4% |
29,328
| – | – |
2015 Q3
7 quarters
|
|
|
71
DELISTED
Du Pont De Nemours E I
DD
| $2.18M | 0.4% |
27,000
| – | – |
2015 Q4
6 quarters
|
|
72
MetLife
MET
$63.7B
| $2.17M | 0.4% |
44,319
| – | – |
2016 Q3
3 quarters
|
|
73
Visa
V
$750B
| $2.16M | 0.4% |
+23,000
| New | +$2.13M |
2017 Q2
0 quarters
|
|
74
DELISTED
Walgreens Boots Alliance
WBA
| $2.11M | 0.39% |
+27,000
| New | +$2.22M |
2017 Q2
0 quarters
|
|
75
Elevance Health
ELV
$92.9B
| $2.07M | 0.38% |
11,000
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
GFA
SL
JFGIW
Cornerstone Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Cornerstone Advisors held 270 positions worth $545M, down 1.6% from $554M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cornerstone Advisors withdrew a net $25.2M in Q2 2017, closing 37 positions and reducing 49 holdings. Its most notable exit was Pfizer, an estimated $6.63M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cornerstone Advisors opened a new position in Meta Platforms (Facebook) worth $10.5M.
- Cornerstone Advisors's largest Q2 2017 buy was Meta Platforms (Facebook): 69,500 shares worth $10.5M.
- Cornerstone Advisors added most to CVS Health in Q2 2017, an estimated $2.29M increase.
- Cornerstone Advisors's biggest Q2 2017 reduction was Morgan Stanley China A Share Fund, cutting an estimated $6.28M.
- Cornerstone Advisors fully exited Pfizer in Q2 2017, selling an estimated $6.63M.
- Cornerstone Advisors's ten largest holdings make up 24% of its $545M portfolio in Q2 2017.
- Cornerstone Advisors opened 49 new positions and closed 37 in Q2 2017.
- Cornerstone Advisors's portfolio value fell 1.6% quarter-over-quarter to $545M.
Based on Cornerstone Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.